Article tools
Author information
Published in Volume 62, Issue 2 (August 1,1978)
J. Clin. Invest. 62(2): 425-435 (1978). doi:10.1172/JCI109144.
Copyright © 1978, The American Society for Clinical Investigation.

Articles

Glucose Intolerance in Uremia: QUANTIFICATION OF PANCREATIC BETA CELL SENSITIVITY TO GLUCOSE AND TISSUE SENSITIVITY TO INSULIN

Ralph A. Defronzo, Jordan D. Tobin, John W. Rowe and Reubin Andres

The Clinical Physiology Branch, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore City Hospitals, Baltimore, Maryland 21224 Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510

Published August 1, 1978

The relative contributions of impaired insulin secretion and of tissue insensitivity to insulin to the carbohydrate intolerance of uremia were investigated in 10 chronically uremic subjects. Two types of glucose-clamp experiments were performed in each patient before and after 10 wk of thrice weekly hemodialysis. In both types the blood glucose concentration was maintained at a constant level by the periodic adjustment of a variable glucose infusion with a negative feedback formula.

Hyperglycemic clamp. The blood glucose concentration was acutely raised and maintained 125 mg/dl above basal levels for 2 h. Since the glucose concentration was held constant, the glucose infusion rate is an index of glucose metabolism (M). After dialysis M increased in all patients from an average of 4.23 to 6.30 mg/kg body wt per min (P < 0.001). The plasma insulin responses (I) both pre- and postdialysis were biphasic with an early burst within the first 2-5 min, followed by a phase of gradually increasing insulin concentration. After dialysis the plasma insulin response diminished slightly. Consequently, the M/I ratio, an index of tissue sensitivity to endogenous insulin, increased postdialysis in all subjects by an average of 92% (P < 0.01).

Euglycemic clamp. The plasma insulin concentration was acutely raised and maintained by a primecontinuous insulin infusion. The blood glucose concentration was held constant at the basal level by a variable glucose infusion as above. M/I again is a measure of tissue sensitivity to insulin (exogenous) and increased in all patients postdialysis by an average of 57% (P < 0.01). In two patients hepatic glucose production was measured with tritiated glucose during the euglycemic clamp and declined by 84% predialysis. A similar decrease (82%) was observed postdialysis. Thus, both the hyperglycemic and euglycemic clamp techniques demonstrated tissue insensitivity to insulin to be the dominant carbohydrate defect in uremia. The surprising apparent lack of consistency in the change in beta cell response postdialysis is explained by the strong inverse correlation between beta cell sensitivity to glucose and tissue sensitivity to insulin (r = -0.920; P < 0.001). Those individuals who showed the most striking improvement in tissue sensitivity to insulin actually decreased their serum insulin response to hyperglycemia; those whose improvement in tissue sensitivity was more modest showed increases in beta cell responses.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 425
icon of scanned page 426
icon of scanned page 427
icon of scanned page 428
icon of scanned page 429
icon of scanned page 430
icon of scanned page 431
icon of scanned page 432
icon of scanned page 433
icon of scanned page 434
icon of scanned page 435
This article Copyright © 1978, The American Society for Clinical Investigation.

Articles that cite
this article:

Factors regulating the disposal of an oral glucose load in normal, diabetic, and obese subjects
Werner K. Waldhäusl, Paul Bratusch-marrain
Diabetes Metab Rev 3(1):79. [CrossRef]

Cellular mechanisms in selected states of insulin resistance: Human obesity, glucocorticoid excess, and chronic renal failure
John M. Amatruda, James N. Livingston, Dean H. Lockwood
Diabetes Metab Rev 1(3):293. [CrossRef]

Insulin aspart: a review
David Owens, Jiten Vora
Expert Opin Drug Metab Toxicol 2(5):793. [CrossRef]

Carbohydrate metabolism in uraemia
Vincent Rigalleau, Henri Gin
Curr Opin Clin Nutr Metab Care 8(4):463. [CrossRef]

Insulin therapy in renal disease
Pedro Iglesias, Juan J. Díez
Diabetes Obes Metab 10(10):811. [CrossRef]

Resistin Serum Levels Are Increased but Not Correlated with Insulin Resistance in Chronic Hemodialysis Patients
Georgios Filippidis, Vasilios Liakopoulos, Peter Rene Mertens, Theodoros Kiropoulos, Nikolaos Stakias, Christina Verikouki, Eftichios Patsidis, Georgios Koukoulis, Ioannis Stefanidis
Blood Purif 23(6):421. [CrossRef]

Malnutrition: a frequent misdiagnosis for hemodialysis patients
William E. Mitch
J Clin Invest 110(4):437. [CrossRef]

ABNORMAL PANCREATIC POLYPEPTIDE RESPONSE TO INTRAVENOUS GLUCOSE IN URAEMICS. A POSSIBLE MECHANISM BEHIND IMPAIRED GLUCOSE TOLERANCE IN URAEMIA
R. Hallgren, K. -E. Fjellstrom, G. Lundquist
Clin Endocrinol (Oxf) 17(2):165. [CrossRef]

Intravenous calcitriol normalizes insulin sensitivity in uremic patients
Alexandra Kautzky-willer, Giovanni Pacini, Ursula Barnas, Bernhard Ludvik, Carola Streli, Helmut Graf, Rudolf Prager
Kidney Int 47(1):200. [CrossRef]

Regulation of myocardial isomyosin V1 in uraemic rats
M. Rambausek, S. Kollmar, D. Klug, O. Mehls, E. Ritz
Eur J Clin Invest 21(1):64. [CrossRef]

Carbohydrate Metabolism in End-Stage Renal Disease
Salim K. Mujais, George Fadda
Semin Dialysis 2(1):46. [CrossRef]

Pattern of growth hormone response to insulin, arginine and haemodialysis in uraemic children
Kunle Ijaiya
Eur J Pediatr 131(3):185. [CrossRef]

Acute renal failure in diabetics
A. Grenfell
Intensive Care Med 12(1):6. [CrossRef]

Reduction of insulin resistance by combined kidney-pancreas transplantation in Type 1 (insulin-dependent) diabetic patients
L. Luzi, A. Secchi, F. Facchini, A. Battezzati, C. Staudacher, D. Spotti, R. Castoldi, G. Ferrari, V. Carlo, G. Pozza
Diabetologica 33(9):549. [CrossRef]

Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions
J. Du, Z. Hu, W. E. Mitch
Eur J Clin Invest 35(3):157. [CrossRef]

The Evidence Against Malnutrition as a Prominent Problem for Chronic Dialysis Patients
Tejinder S. Ahuja, William E. Mitch
Semin Dialysis 17(6):427. [CrossRef]

Nutritional aspects in hemodialysis
Maurice Laville, Denis Fouque
Kidney Int 58(suppl. 76):133. [CrossRef]

1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia
Robert H.K. Mak
Kidney Int 53(5):1353. [CrossRef]

Effect of metabolic acidosis on insulin action and secretion in uremia
Robert H.K. Mak
Kidney Int 54(2):603. [CrossRef]

Post-Transplantation Diabetes Mellitus
Pablo F. Mora
Am J Med Sci 329(2):86. [CrossRef]

Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment
Gregory Holmes, Lawrence Galitz, Peter Hu, William Lyness
Br J Clin Pharmacol 60(5):469. [CrossRef]

Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients
W. Riegel, W. H. Hörl, A. Heidland
Klin Wschr 64(21):1124. [CrossRef]

Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patients
Paolo Fiorina, Franco Folli, Elisabetta Ferrero, Elena Orsenigo, Giovanna Finzi, Gabriella Mazzolari, Claudia Placidi, Lucia Perego, Stefano La Rosa, Marco Melandri
Transpl Int 18(9):1036. [CrossRef]

High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment
E. J. P. De koning, K. A. Fleming, D. W. R. Gray, A. Clark
J Pathol 175(2):253. [CrossRef]

Insulin resistance in uremia mediated by postbinding defects
Douglas Smith, Ralph A Defronzo
Kidney Int 22(1):54. [CrossRef]

Insulin Resistance and Ammo Acid Metabolism in Obesity
BENJAMIN Caballero
Ann N Y Acad Sci 499(1 human obesity):84. [CrossRef]

Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients
E D Siew, L B Pupim, K M Majchrzak, A Shintani, P J Flakoll, T A Ikizler
Kidney Int 71(2):146. [CrossRef]

B-cell response to a standardized breakfast in end-stage renal failure
Jean C. Daubresse, Philippe Henrivaux, François Dehout, Jean C. Meunier, Alfred S. Luyckx, Pierre J. Lefebvre
Acta diabet lat 22(1):9. [CrossRef]

The role of growth hormone in the glucose intolerance of uremia
Ralph A. Defronzo, Jordan Tobin, Gunther Boden, Reubin Andres
Acta diabet lat 16(4):279. [CrossRef]

Atherosclerosis and arteriosclerosis in chronic renal failure
Gérard M London, Tilman B Drüeke
Kidney Int 51(6):1678. [CrossRef]

Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients
Denis Fouque, Susy C Peng, Joel D Kopple
Kidney Int 47(3):876. [CrossRef]

31P NMR spectroscopy investigation of muscle metabolism in hemodialysis patients
Daniel Durozard, Pierre Pimmel, Susana Baretto, Agnès Caillette, Michel Labeeuw, Gabriel Baverel, Paul Zech
Kidney Int 43(4):885. [CrossRef]

Glucose homeostasis and the kidney
Horacio J Adrogué
Kidney Int 42(5):1266. [CrossRef]

Improvement of growth and food utilization by human recombinant growth hormone in uremia
Otto Mehls, Eberhard Ritz, Ernst-B Hunziker, Peter Eggli, Udo Heinrich, Jürgen Zapf
Kidney Int 33(1):45. [CrossRef]

Postbinding defects of insulin action in human adipocytes from uremic patients
Oluf Pedersen, Ole Schmitz, Elisabeth Hjøllund, Bjørn Richelsen, Hans Erik Hansen
Kidney Int 27(5):780. [CrossRef]

Augmented aldosterone and insulin responses to potassium infusion in dogs with renal failure
Michael L Tuck, Mayer B Davidson, Norman Asp, Raymond G Schultze
Kidney Int 30(6):883. [CrossRef]

Induction of insulin resistance in normal adipose tissue by uremic human serum
Michael L Mccaleb, Robert Mevorach, Richard B Freeman, Margaret S Izzo, Dean H Lockwood
Kidney Int 25(2):416. [CrossRef]

Insulin Management of a Diabetic Patient on Hemodialysis
Mark E. Williams
Semin Dialysis 5(1):69. [CrossRef]

What are the Clinically Important Consequences of ESRD-Associated Endocrine Dysfunction?
Mark E. Williams
Semin Dialysis 10(1):16. [CrossRef]

Vitamin D and glucose metabolism in chronic kidney disease
Ian H De boer
17(6):566. [CrossRef]